miR-582-5p inhibits proliferation of hepatocellular carcinoma by targeting CDK1 and AKT3
microRNAs play an important role in the progression of hepatocellular carcinoma (HCC). In this study, we found that miR-582-5p expression was downregulated in hepatoma tissues and HCC cell lines. Upregulation of miR-582-5p reduced colony number, inhibited cellular proliferation, and arrested cell cycle in G0/G1 phase. When miR-582-5p was inhibited, the colony number was increased and cellular proliferation and cell cycle were promoted. Further studies showed that miR-582-5p regulated the progression of HCC through directly inhibiting the expression of CDK1 and AKT3, and indirectly inhibiting the expression of cyclinD1.
KeywordsHepatocellular carcinoma miR-582-5p CDK1 AKT3 CyclinD1
The study was supported by The Natural Science Foundation of China, No: 30371394; Natural Science Fund of Hubei Province, No: 2012FFA044; the Health Department Found of Hubei Province, No: JX6B18; Public Service Platform Construction Projects of Wuhan Technology Bureau, No: 2013060705010326.
Conflicts of interest
- 26.Wu W, Ye H, Wan L, Han X, Wang G, Hu J, et al. Millepachine, a novel chalcone, induces G2/M arrest by inhibiting CDK1 activity and causing apoptosis via ROS-mitochondrial apoptotic pathway in human hepatocarcinoma cells in vitro and in vivo. Carcinogenesis. 2013;34:1636–43.CrossRefPubMedGoogle Scholar
- 29.Yu L, Zhang J, Guo X, Li Z, Zhang P. MicroRNA-224 upregulation and AKT activation synergistically predict poor prognosis in patients with hepatocellular carcinoma. Cancer Epidemiol. 2014;38:408–13.Google Scholar